{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:48:56Z","timestamp":1783075736447,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vaccine.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T16:45:45Z","timestamp":1663433145000},"page":"6225-6234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001\u20132015)"],"prefix":"10.1016","volume":"40","author":[{"given":"Shih-Tsung","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhu-Chering","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.09.002_b0005","doi-asserted-by":"crossref","unstructured":"KM, Shea, J, Edelsberg, D, Weycker, RA, Farkouh, DR, Strutton, SI, Pelton, Rates of pneumococcal disease in adults with chronic medical conditions. Open forum infectious diseases. 2014;1:ofu024.","DOI":"10.1093\/ofid\/ofu024"},{"key":"10.1016\/j.vaccine.2022.09.002_b0010","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/cid\/cis971","article-title":"Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children","volume":"56","author":"Muhammad","year":"2013","journal-title":"Clinical infectious diseases : an official publication of the Infectious Dis Soc Am"},{"key":"10.1016\/j.vaccine.2022.09.002_b0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","article-title":"Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis","volume":"24","author":"van Aalst","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2022.09.002_b0020","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1016\/j.vaccine.2010.07.053","article-title":"Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region","volume":"28","author":"Lin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0025","first-page":"e45","volume":"200","author":"Metlay","year":"2019","journal-title":"Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America American journal of respiratory and critical care medicine"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2022.09.002_b0030","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.vaccine.2015.05.102","article-title":"Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines","volume":"33","author":"Pilishvili","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"Moore","year":"2016","journal-title":"The Lancet Respiratory medicine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0040","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pupt.2014.02.003","article-title":"Pneumococcal vaccines and the prevention of community-acquired pneumonia","volume":"32","author":"Esposito","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2022.09.002_b0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/14760584.2019.1582337","article-title":"Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States","volume":"18","author":"Wiese","year":"2019","journal-title":"Expert review of vaccines"},{"key":"10.1016\/j.vaccine.2022.09.002_b0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41479-017-0030-5","article-title":"Pneumococcal conjugate vaccine implementation in middle-income countries","volume":"9","author":"Tricarico","year":"2017","journal-title":"Pneumonia (Nathan Qld)"},{"key":"10.1016\/j.vaccine.2022.09.002_b0060","first-page":"1","article-title":"Pneumococcal carriage among children in low and lower-middle-income countries: a systematic review","volume":"115","author":"Tvedskov","year":"2022","journal-title":"Int j infectious dis: IJID : official publication of the Int Soc Infectious Dis"},{"key":"10.1016\/j.vaccine.2022.09.002_b0065","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.vaccine.2019.08.073","article-title":"Using pneumococcal carriage studies to monitor vaccine impact in low- and middle-income countries","volume":"37","author":"Chan","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7774\/cevr.2015.4.2.121","article-title":"Pneumococcal disease and use of pneumococcal vaccines in Taiwan","volume":"4","author":"Wei","year":"2015","journal-title":"Clin experimental vaccine res"},{"key":"10.1016\/j.vaccine.2022.09.002_b0075","unstructured":"Organization WH. Position paper on pneumococcal conjugate vaccines (PCV) - February 2019."},{"key":"10.1016\/j.vaccine.2022.09.002_b0080","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0000000000000565","article-title":"Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine","volume":"34","author":"Wei","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.09.002_b0085","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2009.06.091","article-title":"National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential","volume":"27","author":"Hsieh","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0090","first-page":"945","article-title":"A 6-year retrospective epidemiologic study of pediatric pneumococcal pneumonia in Taiwan. journal of the formosan medical association =","volume":"107","author":"Huang","year":"2008","journal-title":"Taiwan yi zhi"},{"key":"10.1016\/j.vaccine.2022.09.002_b0095","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"The New England j med"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.09.002_b0100","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2022.09.002_b0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jmii.2016.08.009","article-title":"Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan. Journal of microbiology, immunology, and infection =","volume":"51","author":"Chi","year":"2018","journal-title":"Wei mian yu gan ran za zhi"},{"key":"10.1016\/j.vaccine.2022.09.002_b0110","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jval.2011.11.013","article-title":"Cost-effectiveness analysis of pneumococcal conjugate vaccine in Taiwan: a transmission dynamic modeling approach","volume":"15","author":"Wu","year":"2012","journal-title":"Value in health : the journal of the Int Soc Pharmacoeconomics and Outcomes Res"},{"key":"10.1016\/j.vaccine.2022.09.002_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12916-015-0446-9","article-title":"The broader economic impact of vaccination: reviewing and appraising the strength of evidence","volume":"13","author":"Jit","year":"2015","journal-title":"BMC medicine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0120","article-title":"Using Taiwan's national health insurance research databases for pharmacoepidemiology research","volume":"15","author":"Hsiao","year":"2007","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.vaccine.2022.09.002_b0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11192-010-0289-2","article-title":"Taiwan\u2019s National Health Insurance Research Database: administrative health care database as study object in bibliometrics","volume":"86","author":"Chen","year":"2011","journal-title":"Scientometrics"},{"key":"10.1016\/j.vaccine.2022.09.002_b0130","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/ciy800","article-title":"Decline in pneumococcal disease attenuated in older adults and those with comorbidities following universal Childhood PCV13 Immunization","volume":"68","author":"Pelton","year":"2019","journal-title":"Clin infectious dis: an official publication of the Infectious Dis Soc Am"},{"key":"10.1016\/j.vaccine.2022.09.002_b0135","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.09.002_b0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.vaccine.2022.09.002_b0145","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1016\/j.vaccine.2019.07.073","article-title":"Evaluation of the impact of 13-valent pneumococcal conjugate vaccine immunization in children by surveillance of culture-confirmed pneumococcal disease: a prospective clinical microbiological study","volume":"37","author":"Chen","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jmii.2017.08.022","article-title":"Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules. Journal of microbiology, immunology, and infection =","volume":"51","author":"Lee","year":"2018","journal-title":"Wei mian yu gan ran za zhi"},{"key":"10.1016\/j.vaccine.2022.09.002_b0155","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/INF.0000000000001054","article-title":"Effectiveness of pneumococcal conjugate vaccines of different valences against invasive pneumococcal disease among children in taiwan: a nationwide study","volume":"35","author":"Su","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.09.002_b0160","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/cid\/ciy1127","article-title":"Successful Control of Streptococcus pneumoniae 19A Replacement With a Catch-up Primary Vaccination Program in Taiwan","volume":"69","author":"Lu","year":"2019","journal-title":"Clin infectious dis : an official publication of the Infectious Dis Soc Am"},{"key":"10.1016\/j.vaccine.2022.09.002_b0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0032-1310103","article-title":"The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ","volume":"66","author":"Pletz","year":"2012","journal-title":"Pneumologie (Stuttgart, Germany)"},{"key":"10.1016\/j.vaccine.2022.09.002_b0170","first-page":"3605834","article-title":"A retrospective study of the clinical burden of hospitalized all-cause and pneumococcal pneumonia in canada","author":"McNeil","year":"2016","journal-title":"Canadian respiratory j"},{"key":"10.1016\/j.vaccine.2022.09.002_b0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3111\/13696998.2014.898644","article-title":"A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan","volume":"17","author":"Wu","year":"2014","journal-title":"J med economics"},{"key":"10.1016\/j.vaccine.2022.09.002_b0180","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/21645515.2015.1023969","article-title":"The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program","volume":"11","author":"Ho","year":"2015","journal-title":"Human vaccines & immunotherap"},{"key":"10.1016\/j.vaccine.2022.09.002_b0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jmii.2014.05.007","article-title":"Population-based incidence of community-acquired pneumonia hospitalization in Hong Kong children younger than 5 years before universal conjugate pneumococcal immunization. journal of microbiology, immunology, and infection =","volume":"49","author":"Chiu","year":"2016","journal-title":"Wei mian yu gan ran za zhi"},{"key":"10.1016\/j.vaccine.2022.09.002_b0190","unstructured":"Control TCfD. Invasive Pneumococcal Disease."},{"key":"10.1016\/j.vaccine.2022.09.002_b0195","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.vaccine.2015.04.068","article-title":"The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old\u2013Taiwan's PPV vaccination program","volume":"33","author":"Tsai","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0200","article-title":"Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan: a nation-wide community-based study","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0205","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"The Lancet Global health"},{"key":"10.1016\/j.vaccine.2022.09.002_b0210","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2017.04.032","article-title":"Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: a systematic review of the literature","volume":"35","author":"Tsaban","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0215","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.vaccine.2015.11.060","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands","volume":"34","author":"Bosch","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.09.002_b0220","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22010842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:17:52Z","timestamp":1759403872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22010842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":44,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0264410X22010842"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001\u20132015)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}